RTTN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.323000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.840600E-01
Normal-vs-Stage2
4.232200E-01
Normal-vs-Stage3
2.742400E-01
Normal-vs-Stage4
1.748830E-01
Stage1-vs-Stage2
6.750000E-02
Stage1-vs-Stage3
5.484400E-02
Stage1-vs-Stage4
9.411700E-02
Stage2-vs-Stage3
1.361990E-01
Stage2-vs-Stage4
2.084600E-01
Stage3-vs-Stage4
8.175400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.447000E-01
Normal-vs-AfricanAmerican
4.516000E-01
Normal-vs-Asian
3.147200E-01
Caucasian-vs-AfricanAmerican
9.973800E-01
Caucasian-vs-Asian
6.497700E-02
AfricanAmerican-vs-Asian
1.144620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.139400E-01
Normal-vs-Female
4.559400E-01
Male-vs-Female
3.053000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.143200E-01
Normal-vs-Age(41-60Yrs)
4.988800E-01
Normal-vs-Age(61-80Yrs)
3.877600E-01
Normal-vs-Age(81-100Yrs)
5.271400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.076400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.003570E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.340800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.325780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.233000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.995800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.753000E-01
Normal-vs-Daily Drinker
1.981420E-01
Normal-vs-Weekly Drinker
3.481000E-01
Normal-vs-Occasional Drinker
4.752400E-01
Normal-vs-Social Drinker
2.474400E-01
Non Drinker-vs-Daily Drinker
1.047410E-01
Non Drinker-vs-Weekly Drinker
5.874800E-01
Non Drinker-vs-Occasional Drinker
1.603960E-01
Non Drinker-vs-Social Drinker
1.203960E-01
Daily Drinker-vs-Weekly Drinker
5.348200E-02
Daily Drinker-vs-Occasional Drinker
7.138400E-01
Daily Drinker-vs-Social Drinker
8.965800E-01
Weekly Drinker-vs-Occasional Drinker
1.187220E-01
Weekly Drinker-vs-Social Drinker
6.696000E-02
Occasional Drinker-vs-Social Drinker
6.280200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.494420E-01
Normal-vs-Grade 2
7.206200E-02
Normal-vs-Grade 3
1.557560E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.588640E-01
Grade 1-vs-Grade 3
5.049400E-01
Grade 1-vs-Grade 4
1.494420E-01
Grade 2-vs-Grade 3
1.670770E-01
Grade 2-vs-Grade 4
7.206200E-02
Grade 3-vs-Grade 4
1.557560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.175000E-01
Normal-vs-NonDiabetic
4.294600E-01
Diabetic-vs-NonDiabetic
7.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.850200E-01
Normal-vs-NoPancreatitis
4.102200E-01
Pancreatitis-vs-NoPancreatitis
3.651200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.402600E-01
Normal-vs-N1
4.241000E-01
N0-vs-N1
7.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.391600E-01
Normal-vs-TP53-NonMutant
5.831800E-01
TP53-Mutant-vs-TP53-NonMutant
2.783700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
